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1. INTRODUCTION 
A number of antibiotics have been used as in- 
hibitors in the study of electron transport through 
the ubiquinone: cyt. c oxidoreductase (b-cl com- 
plex) of mitochondria and photosynthetic bacteria. 
Myxothiazol, a new antibiotic inhibitor, has been 
introduced to the study of the mitochondrial chain 
[l-4]. Myxothiazol has been shown to inhibit elec- 
tron transport through the b-cl complex of 
mitochondria or submitochondrial particles, by 
blocking the reduction of cytochromes c and cl by 
succinate or NADH. In the presence of antimycin, 
but not in its absence, myxothiazol also inhibited 
reduction of the b-type cytochromes by succinate 
or NADH [3,4]. This pattern of inhibition was 
quite distinct from that of antimycin, and sug- 
gested a different site of action. In confirmation of 
this, the binding of myxothiazol and of antimycin, 
as assayed by tritration, were independent [4], and 
myxothiazol induced a red shift in a b cytochrome 
which was independent of and additive to the 
antimycin-induced red shift [3]. The structure and 
physical properties of myxothiazol have also been 
determined and are given in [2,3]. 
[5-71 and might therefore be expected to be sen- 
sitive to the same antibiotics. Here, we present an 
initial report on the effects of myxothiazol on the 
bacterial b-cl complex, and show the site and 
mechanisms of inhibition in the electron-transfer 
chain. 
2. MATERIALS AND METHODS 
The kinetics of flash-induced changes in redox 
state of components of the chain, and the 
dependence of these on ambient potential were 
measured using a computer-linked kinetic spec- 
trophotometer and redox titration assembly as in 
[8,9]. Redox poising was done as in [lo]. Spectra 
were obtained using a computer-linked scanning 
spectrophotometer [9]. Antimycin was obtained 
from Sigma and 2-hydroxy-3-undecyl-1,4- 
naphthoquinone (UHNQ) was obtained from 
Aldrich. 5-n-undecyl-6-hydroxy-4,7-dioxobenzo- 
thiazole (UHDBT) was a gift from Dr B.L. Trum- 
power and myxothiazol was a kind gift from Drs 
Reichenbach, G. Thierbach and W. Trowitzsch. 
Cells or chromatophores from the photosyn- 
thetic bacterium Rhodopseudomonas phaeroides 
contain a ubiquinol : cyt. cz oxidoreductase which 
functions in photosynthetic cyclic electron- 
transport chain. The bacterial b-cl complex ap- 
pears to be completely analogous to the mitochon- 
drial b-cl complex in both structure and function 
3. RESULTS AND DISCUSSION 
The effect of myxothiazol on the kinetic changes 
of cyt. cl + CZ, and cyt. b561 following a series of 
flashes are shown in fig. 1. At an ambient redox 
potential (&) of 100 mV, flash illumination of un- 
coupled chromatophores induced a rapid oxidation 
cyt. ct (cyt. cz plus cyt. cl, measured at 
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551-542 nm 567 -569 nm 
Fig 1. The effects of inhibitors on the absorption 
changes of cytochromes ct and 6566. Chromatophores 
from Rps. sphaeroides strain Ga were suspended to 
0.56pM [reaction center] in buffer (50mM MOPS, 
1OOmM KCI) at pH7. Traces are an average of 4, with 
IOOms sweep full scale, and the instrument response 
time was 200~s. The potential was adjusted to 
113 + 3 mV by small additions of solutions of concen- 
trated potassium ferricyanide or sodium dithionite. The 
mediators present were as follows: lO$M l,Cnaphtho- 
quinone, 1 ,Znapthoquinone, duroquinone and p-benzo- 
quinone; 2pM DAD; IpM PMS, PES and pyocyanin. 
Also present, at 2pM each, were vaIinomycin and 
nigericin: (a-f) from one sample; (g-h) from a second 
sample; (a,b) in the absence of inhibitors; (c,d) obtained 
from the same sample after the addition of 10,uM anti- 
mycin; (e,f) cytochrome kinetics after 3pM myxothiazol 
was added to the sample used for traces (c,d); (g,h) 
cytochrome changes in the presence of the mediators 
above and IOpM antimycin and 80bM UHNQ; (ij) 
cytochrome changes after the addition of 12rM 
myxothiazol of the sample used for (g,h). 
551--542nm), which was followed by a complete 
re-reduction with tlf2 1.5 ms, and a transient reduc- 
tion and reoxidation of cyt. b56t (traces a,b). Addi- 
tion of antimycin inhibited the oxidation of cyt. 
b56r and partially inhibited the re-reduction of cyt. 
551- 542 nm Eh=103t3mV 
5ms 
Fig. 2. Kinetics of cytochrome ct in the presence of 
several different inhibitors. Chromatophores (0.42pM 
reaction center) were suspended in the same buffer and 
with the same mediators as in fig. 1. Traces are an 
average of 16 (IOms sweep time, instrument response 
20+): {a) absence of inhibitors; (b) presence of IOpM 
antimycin; (c) presence of myxothiazo1 (12pM); (d) 
presence of UHNQ (80gM); (e) difference (a-b) shows 
the antimycin-sensitive cyt. c mediation; (f) difference 
(b-c) showing the myxothiazol-sensitive phase of cyt. cr 
re-reduction which is antimycin-insensitive; (g) dif- 
ference (c-d) showing the UHNQ-sensitive phase of cyt. 
q re-reduction which is insensitive to both myxothiazol 
and antimycin. 
ct (ci + ~2) (c,d). Addition of myxothiazol to an- 
timycin inhibited chromatophores caused a com- 
plete inhibition of the reduction of cyt. 6~61 and a 
greater inhibition of cyt. ct re-reduction (e,f). 
UHDBT or UHNQ, added instead of myxothiazol, 
had a similar effect on the kinetics of the b- and c- 
type cytochromes (g,h), but comparison of the ef- 
fects of UHNQ and myxothiazol on cyt. ct re- 
reduction following the first flash, shows that in 
the presence of myxothiazol a partial re-reduction 
of the c-type cytochromes had occurred which was 
eliminated by UHNQ, leaving cyt . ct more oxidized 
in the presence of UHNQ. The additional re-reduc- 
tion of qt. ct on the first flash seen in the presence 
of myxothiazol, but not with UHNQ, suggests that 
a component was able to donate electrons to the c- 
type cytochromes, in a reaction which was insen- 
sitive to myxothiazol, but sensitive to UHNQ. 
Addition of myxothiazoi in the absence or 
presence of antimycin led to kinetic traces similar 
to those of fig. 1 (e,f) with a titration showing half- 
maximal effect at 0.45,~M (1.7 myxothiazol/cyt. 
&i) and complete inhibition at 3pM, independent 
of the presence of antimycin. In the presence of 
80,~M UHNQ or 12frM UHDBT giving maximal 
218 
Volume 149, number 2 FEBS LETTERS November 1982 
inhibition, addition of myxothiazol had little effect 
at concentrations which produced half-maximal in- 
hibition in the absence of UHNQ or UHDBT. 
However, as the concentration of myxothiazol was 
increased, the extra oxidation induced by addition 
of UHNQ or UHDBT was lost, so that at > 12pM 
myxothiazol the kinetic traces in the presence of 
UHNQ were the same as in its absence (trace (i)). 
The ability of myxothiazol to reverse the effects of 
UHNQ or UHDBT suggests that it is able to dis- 
place UHNQ and UHDBT from their binding site, 
and that these inhibitors have a common binding 
site with myxothiazol. 
In fig. 2 kinetic traces are shown on a faster time 
scale of the cyt. ct and cyt. b561 changes induced by 
single turnover flash, 90% saturating, in the 
presence of different inhibitors. From these traces 
three different phases of cyt. ct re-reduction can be 
determined: 
(9 
(ii) 
(iii) 
The antimycin-sensitive phase (e), shown by 
the difference between the kinetics with no ad- 
dition (a), and with antimycin present (b), has 
a half-time of 0.6 ms, after a lag of 0.5 ms. 
The antimycin-insensitive but myxothiazol- 
sensitive phase (f) (traces (c-b)), has a similar 
half-time; 
The UHNQ-sensitive but myxothiazol- 
insensitive phase of cyt. ct re-reduction (g), 
(traces (d-e)) has a half-time of 200-250~s. 
In fig. 3 titrations are shown of the extent of cyt. 
c2 + cl oxidation in the presence of myxothiazol 
and UHNQ, and the difference, showing the 
myxothiazol-insensitive, UHNQ-sensitive cyt. c, 
reduction following a single flash, as a function of 
Eh. The titration of the UHNQ-sensitive but myxo- 
thiazol-insensitive cyt. ct re-reduction should show 
the midpoint(s) of the component(s) providing the 
extra electrons for the re-reduction of cyt. ct. This 
titration curve can be well fitted by a single one- 
electron component with an Em7 of 286mV, 
characteristics similar to those of the Rieske 
iron-sulfur center (Em7 = 290mV, n = 1). 
To discuss the differential effects of the three 
types of inhibitor used here, we must introduce a 
model for the mechanism of ubiquinol-cyt. cz ox- 
idoreductase. We have suggested a modified Q- 
cycle model with the following features [11,12]: 
(1) The complex acts to oxidize ubiquinol from 
the pool, and reduce cyt. cz in reactions which are 
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Fig. 3. A redox titration of the extent of cytochrome ct 
oxidation in the presence of UHNQ or myxothiazol. 
Chromatophores (0.43pM reaction center) were 
suspended in the same buffer and with the same 
mediators as in fig. 1. Antimycin A (1OrM) was also 
added. The redox potential was adjusted by small addi- 
tions of solutions of concentrated sodium dithionite or 
potassium ferricyanide. The extent of oxidation of cyt. 
c was measured 32 ms after a single 90% saturating flash 
from traces (av. 2, sweep = lOOms, 200~s instrument 
response time) obtained at each potential shown. 
Cytochrome ct kinetics were measured at 551-542nm: 
(A) oxidation in the presence of UHNQ (80pM); (0) ox- 
idation in the presence of myxothiazol (12pM); (0) dif- 
ference in the extent of oxidation between UHNQ and 
myxothiazol. 
kinetically independent of the photochemical reac- 
tion center. 
(2) The complex has two catalytic sites at which 
quinone and quinol from the pool can react: 
Site (i) is a ubiquinol:FeS, ferricyt. b566 oxido- 
reductase site, catalyzing a concerted reac- 
tion in which one electron from QH2 is passed to 
a high potential chain of electron carriers in 
series consisting of FeS, cyt. cl, cyt. cz (or cyt. 
c) and P (or cytochrome oxidase), and a second 
electron is passed to a low potential chain con- 
sisting Of Cyt. b566 and Cyt. b56l; 
219 
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Site (ii) catalyzes a ferricyt. b: ubiquinone oxido- 
reductase reaction, in which two electrons stored 
on the b-type cytochromes can reduce ubi- 
quinone to the quinol. 
We have suggested that antimycin completely 
blocks all reaction at site (ii), possibly by displacing 
the quinone and quinol species from their binding 
site [7]. 
(3) To turn over completely, the quinol oxidase 
site has to turn over twice (introducing 2 electrons 
into the b-cytochrome chain), and the quinone 
reductase site turns over once, to give a net oxida- 
tion of 1 quinone/complex. 
(4) In the presence of antimycin, electrons cannot 
leave the 6-cytochrome chain, and the quinol ox- 
idase site is constrained to ~2 turnovers for 
thermodynamic reasons. 
Based on the above results, we suggest hat myx- 
othiazol binds to the ubiquinol oxidase site of the 
b-cl complex, as do UHNQ and UHDBT. Unlike 
the quinone analogues, myxothiazol does not ef- 
fect the redox properties, or inhibit oxidation, of 
the Rieske FeS center, but does inhibit its reduction 
by ubiquinol from the pool. We further suggest 
that the component providing electrons for the re- 
reduction of cyt. ct in the presence of myxothiazol 
is the Rieske FeS center, since both UHDBT and 
UHNQ inhibit the oxidation of the Rieske FeS 
center, but have no effect on the oxidation of the 
c cytochromes [ 13,141. From these facts we con- 
clude that the Rieske FeS center can be oxidized in 
the presence of myxothiazol. In terms of a Q-cycle 
model, this proposed site of action would also ex- 
plain the inhibition of cyt. b~i reduction, since 
binding of myxothiazol to the ubiquinol oxidase 
site would prevent the binding of QH2, and its ox- 
idation, which are necessary for the reduction of 
cyt. bsal_ If our proposal is correct, then the rate 
of oxidation of the Rieske FeS center can be 
measured by the difference between the cyt. ct 
kinetics measured in the presence of UHNQ, which 
prevents the oxidation of the FeS center, and the 
kinetics measured in the presence of myxothiazol, 
which inhibits the reduction of the FeS center. This 
difference is shown in fig. 2g and gives a half-time 
of 200~s for the oxidation of the Rieske FeS 
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center, after a lag of -50,~s. This half-time fits 
nicely with a scheme in which the FeS center, and 
cytochromes cl and cz form a linear chain, and 
with the measured half-times of oxidation of 
cytochrome cz (4-10,~), and cytochrome CI 
(15Ors) [51. 
In fig. 4 difference spectra are shown induced by 
addition of the antimycin or myxothiazol to 
chromatophores with cytochrome b reduced. In 
the presence of excess dithionite the addition of 
antimycin induced a shift in the absorption of the 
b cytochrome(s) as reported in [15] (a). Further ad- 
dition of myxothiazol to this sample produced a 
narrowing of the shift (b). The difference (c) shows 
a blue shift with a maximum and minimum at 
562 nm and 568 nm, respectively, and a crossover 
point at 565 nm. The myxothiazol-induced shift 
was independent of the presence of antimycin and 
the antimycin-induced shift was independent of 
myxothiazol as is shown in (d-f). In (d) the addi- 
tion of myxothiazol induced a blue shift. The 
l,l.lll,l.,* ,,,,,,,.I,,, 
520 530 540 550 560 570 520 530 540 550 560 570 
nm “Ill 
Fig. 4. Difference spectra of changes in b-type cyto- 
chromes induced by addition of inhibitors. Chromato- 
phores were suspended to -3,uM reaction center in 
50mM MES, 1OOmM KC1 (pH6) in an open cuvette, a 
crystal of sodium dithionite was added, and the pH ad- 
justed to 5.75 f 0.03: (a-c) represent one sample; (d-f) 
a second sample; (a) difference between the spectrum 
with antimycin (10,~M) and that without inhibitor; (b) 
difference between the spectrum with antimycin and 
myxothiazol (12pM), and that without inhibitors; (c) is 
difference (a-b); (d) difference between the spectrum 
with myxothiazol (12pM) and that without inhibitor; (e) 
is the same difference as shown in (b), but after the addi- 
tion of antimycin (1OpM) to the myxothiazol-treated 
sample; (f) difference (d-e). 
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subsequent addition of antimycin (e) gave an ap- cytochrome, but is independent of antimycin. 
parently narrowed antimycin shift, the difference Finally myxothiazol appears to have a specific bin- 
(f) gives the normal antimycin shift. Preliminary ding site of high affinity and completely inhibits 
results from redox titrations suggest hat the shift electron transport at 3 myxothiazol/oxidoreduc- 
induced by myxothiazol is a blue shift in the tase complex. The suggested mode of action ex- 
566 nm peak of cytochrome b566 (double LY band at plains the effects of myxothiazol observed on mito- 
559nm and 566 nm, Em7 = - 9OmV), and that chondrial electron transfer, and on the kinetics of 
myxothiazol may also change the value of E,,, the isolated cyt. b-cl complex, and our model is 
for cyt. bs66 by 30-60mV (from -90 to - 45 compatible with suggestions for the site of action 
+ 15 mV). Myxothiazol has no effect on the spec- suggested from work with mitochondrial systems 
tra or midpoints of the other b cytochromes. t3,41. 
These results provide several clues as to the 
relative positions and reactions of the b-type cyto- 
chromes and the Rieske FeS center. Since myx- 
othiazol reacts with cyt. b566, and displaces UHNQ 
or UHDBT from the Rieske FeS-center, it appears 
that these redox components must be relatively 
close to each other, and that their proteins may 
form the reaction site at which ubiquinol from the 
pool is oxidized [ 1 l-131. The main effect of anti- 
mycin is to induce a red shift in cyt. b561, although 
the broader red lobe of the antimycin-induced if- 
ference spectrum suggests that the spectral change 
may contain a small contribution from cyt. bs66. 
The independence of the effects of myxothiazol 
and antimycin, both with respect to titration, and 
to induced band shift, show that the two inhibitors 
bind at different sites. We may conclude that the 
heme of cyt. bs6l is closely associated with the 
antimycin-sensitive site, identified as the ferrocyt. 
b : ubiquinone oxidoreductase site of the complex. 
This distribution of cyt. b hemes is consistent with 
our earlier suggestion that cyt. b566 and cyt. b561 
form a serial electron-transfer chain across the 
membrane connecting the ubiquinol oxidase and 
ubiquinone reductase sites of the chromatophore 
complex [ 11,121, as has also been suggested for the 
mitochondrial complex [6,16,18]. 
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